Figure S8 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice
Gabrilo J., Vande Velde S., Henin C., Denanglaire S., Azouz A., Boon L., Van den Eynde BJ., Moser M., Goriely S., Leo O.
Enhanced antigen-presenting capacity is associated with subsets exhibiting elevated expression of MHC II